About
Physician-scientist trained at Cambridge and Oxford specializing in neurology, formerly at AstraZeneca Neuroscience and an EIR at several life-science funds. Focus area: biotech.
Experience
- TRIMTECH Therapeutics LimitedHead of Researchcurrent2024 β presentCambridge, England, United Kingdom
- TRIMTECH Therapeutics LimitedFounder & Head of Research and Translational Sciences2024Cambridge, England, United Kingdom
- TRIMTECH Therapeutics LimitedFounding CEO2023 β 2024Cambridge, England, United Kingdom
- Dementia Discovery Fund (DDF)Entrepreneur In Residencecurrent2022 β presentLondon, England, United Kingdom
- Parkinson's UKMember of Parkinson's UK Drug Discovery Advisory Panelcurrent2022 β presentGreater London, England, United Kingdom
- Cambridge Innovation CapitalEntrepreneur In Residencecurrent2022 β presentCambridgeshire, England, United Kingdom
- UCLHonorary Associate Professorcurrent2020 β presentLondon, England Metropolitan Area
- Picus CapitalExpert Partnercurrent2023 β presentCambridge, England, United Kingdom
- Medical and More LimitedSoftware Developercurrent2018 β presentCambridge, England, United Kingdom
- Drishti DiscoveriesNon Executive Director2023 β 2024Cambridgeshire, England, United Kingdom
- EndLyz TherapeuticsNon Executive Director2021 β 2022Boston, Massachusetts, United States
- Oxford Science EnterprisesEntrepreneur In Residence2021 β 2022Oxford, England, United Kingdom
- Oxford Science EnterprisesConsultant2020 β 2021Oxford, England, United Kingdom
- AstraZenecaHead of Early Discovery2019 β 2021Granta Park, Cambridge, UK
- AstraZenecaDirector, R&D2015 β 2021Granta Park, Cambridge
- Fisher HouseTreasurer2017 β 2020Cambridge, England, United Kingdom
- Oxbridge Solutions LtdTechnical Director1991 β 2018www.gpnotebook.com
- MedImmuneDirector, R&D2015 β 2016Cambridge, United Kingdom
- Trinity HallFellow2007 β 2014
- University of CambridgeResearch Group Leader2000 β 2014Department of Genetics
- University of CambridgeHonorary Registrar in Clinical Neurology1999 β 2003Addenbrookes Hospital, Cambridge
- Alzheimer's Research UKSenior Research Fellow2010 β 2013
Skills & more
Drug DevelopmentProject ManagementEntrepreneurshipVenture FinancingMolecular Biology47Biochemistry46Lifesciences8Biotechnology10Drug Discovery22Neuroscience35Research14Science17
+12 more
CancerProtein ChemistryMicroscopyCell CultureGeneticsCell BiologyBioinformaticsChemistryGenomicsProtein ExpressionPhysicsPCRLanguages French Β· Italian
From Damian's professional profile.
Colleagues at PICUS CAPITAL
Abhijay Thacker
Investment Advisor at PICUS CAPITAL
Alex Smola
CEO and Co-Founder of Boson AI at PICUS CAPITAL
Alexander Samwer
Founding Partner at PICUS CAPITAL
Amit Jain
CEO at Rewired
Andreas Stryz
CTO at FINN at PICUS CAPITAL
Andy Cohen
SVP of Sales at Bill.com at PICUS CAPITAL
Annika in der Beek
Chief People Officer at Statista at PICUS CAPITAL
Anselm Bauer
Co-Founder at Alasco at PICUS CAPITAL
Frequently asked questions
- Who is Damian Crowther?
- Physician-scientist trained at Cambridge and Oxford specializing in neurology, formerly at AstraZeneca Neuroscience and an EIR at several life-science funds. Focus area: biotech.
- Where does Damian Crowther work?
- Damian Crowther is ex-AstraZeneca at PICUS CAPITAL.
- Where did Damian Crowther go to school?
- Damian Crowther studied at Royal College of Physicians (London) (FRCP, Medicine); Royal College of Physicians (London) (MRCP, Clinical Medicine); University of Oxford (BM BCh, Clinical Medicine).
Same school
Also attended University of Oxford989
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index Ventures
+ 983 more
Also attended University of Cambridge894
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
+ 888 more
Also attended The Manchester Grammar School10
Danny BrowneInvestor at FJ LabsWill DuftonPartner at Giant Ventures Global LlpCharlie LeggatePartner at Anorak VenturesMarcusGlobal Head of Regulatory Strategy at SENTINEL GLOBALKyle BentwoodPartner & Head of Origination at Bridges Fund Management Ltd.Cedric Van DuffelSenior Associate at Mouro Capital
+ 4 more
Shared employers
Also worked at TRIMTECH Therapeutics Limited3
Also worked at UCL82
Demis HassabisCo-founder & CEO of Google DeepMindItxaso del PalacioGeneral Partner at Notion CapitalTess van StekelenburgPartner at Lux CapitalFrancesco MonacaInvestor at Giant Ventures Global LlpDima KuzminManaging Partner at 4BIO CapitalTherese LiechtensteinPartner at 4BIO Capital
+ 76 more
Also worked at Oxford Science Enterprises18
Isabel FoxHead of Investor Relations at Hoxton VenturesNarges BaniasadiVenture Partner at Think+ Ventures Management, LlcSarah ShackeltonAdvisor at Delin VenturesJonathan HeppleManaging Partner at Rosetta Capital Ltd.Tom CaponPrincipal at Optum VenturesTim FunnellPartner at Monograph Capital Partners
+ 12 more
Also worked at AstraZeneca60
Detlev BiniszkiewiczManaging Director at MPM BioImpactBriggs MorrisonEntrepreneur Partner at MPM BioImpactJung Lee, PhDVenture Partner at Adelphi Ventures Management, LlcJohan LundVenture Partner at ScietyAnnie VemuSenior Associate at Longwood FundIliam BarkinoInvestor at Industrifonden
+ 54 more






















.png)


























